Periorbital cellulitis

Revision as of 17:03, 24 July 2016 by Neil.m.young (talk | contribs) (Text replacement - "==Diagnosis==" to "==Evaluation==")

Background

  • Most often due to contiguous infection of soft tissues of face and eyelids
  • Most patients are <10yr
  • Rarely leads to orbital cellulitis

Periorbital vs Orbital Cellulitis

Clinical Features

  • Swelling and erythema of tissues surrounding the orbit
  • +/- pain with eye movement
  • +/- fever
  • Lack of:
    • Proptosis
    • Chemosis
    • Globe displacement
    • Limitation of eye movements
    • Double vision
    • Vision loss (indicates orbital apex involvement)

Differential Diagnosis

Periorbital swelling

Proptosis

No proptosis

Lid Complications

Other

Evaluation

  • CT Orbit with IV contrast if:
    • Concern for orbital cellulitis
    • Unable to accurately assess vision (e.g. age <1yr)

Management

Antibiotics

Outpatient

Treatment recommended for 5-7 days. If signs of cellulitis persist at the end of this period, treatment should be continued until the eyelid erythema and swelling have resolved or nearly resolved.

- In children: 8 to 12 mg/kg QD of the TMP component divided every 12 hours

- In children: 30 to 40 mg/kg per day in three to four equally divided doses, maximum 1.8 grams per day

PLUS one of the following agents:

- In children: usual dosing is 45 mg/kg per day divided every 12 hours; dosing for severe infections or when penicillin-resistant S. pneumoniae is a concern (using the 600 mg/5 mL suspension) is 90 mg/kg per day divided every 12 hours

- In children <12 years of age: 10 mg/kg per day divided every 12 hours, usual maximum dose 200 mg; in children ≥12 years and adolescents: 400 mg every 12 hours

- In children: 14 mg/kg per day, divided every 12 hours, maximum daily dose 600 mg

Inpatient

Vancomycin 15-20mg/kg IV BID + (one of the following)

Disposition

  • If well-appearing and afebrile consider discharge

See Also

References